CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

HARVARD BIOSCIENCE Aktie

HARVARD BIOSCIENCE INC. REGISTERED SHARES DL -,01

ISIN: US4169061052

 | 

WKN: 578107

 | 

Symbol: HBI

 | 

Land: USA


2,90 EUR 0,5901%

Die besten Rohstoffaktien der Welt

Zu Ihrem Onlinebroker

kaufen verkaufen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen

HARVARD BIOSCIENCE Aktienkurs

: 25.05. ( 15 Min. verzögert)
2,90 €
Letzter Kurs
 0,59%
Veränderung
 2,88 €
Vortag
 2,88 €
Eröffnungskurs

Alle News aus dem Web zur HARVARD BIOSCIENCE Aktie

  • 16.05.

    Table of Unusual NASDAQ Stock Moves From RealTick

    ... BANCORP CO NBN 8.00 -2.06 -20.48 4 HARVARD BIOSCIENCE I HBIO 3.78 -0.20 -5.03 5 ORASURE TECHNOLOGIES OSUR 10.92 1.82 20.00 RealTick provides a real-time service that measures unusual...

  • 04.05.

    Business Digest for May 4

    Harvard Bioscience Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, Thursday reported unaudited financial res…

  • 03.05.

    DIARY-NON S&P - DAY AHEAD

    ... Celestial Group 0.50 11 0.36 03 May AMC Q2 2012 Haynes International Inc 1.04 5 0.51 03 May BMO Q1 2012 Harvard Bioscience, Inc. N/AN/AN/A 03 May Q1 2012 HCA 0.95 20 0.85 03 May AMC Q1 2012 HERITAGE-CRYSTAL CLEAN ...

  • 03.05.

    DIARY - US Company Conference Call/Webcast for Day Ahead

    ... May 15:00 Fuel Systems' First Quarter Results Call 03 May 15:00 Q1 Geeknet, Inc. Earnings Conf Call 03 May 15:00 Q1 Harvard Bioscience, Inc. Earnings Conf Call 03 May 15:00 Q1 Infinity Property & Casualty Corp.

  • 03.05.

    Harvard Bioscience, Inc. (HBIO) Reports Q1 EPS of $0.09; Guides Q2

    ... $0.09, versus $0.08 reported last year. Revenue for the quarter came in at $28.3 million, versus $26.3 million reported last year. Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06.